Explore Diverse Views.
Published loading...Updated

Sony, Partners Trial MEA System with 237,000 Electrodes

  • Sony Semiconductor Solutions, SCREEN Holdings, and VitroVo jointly announced a trial of a high-density MEA system in Tokyo on June 2, 2025.
  • The collaboration, with cooperation from the Tohoku Institute of Technology, developed this system to enable detailed cellular electrical activity observation.
  • The CMOS-MEA device uses complementary metal-oxide-semiconductor technology with approximately 237,000 electrodes in a compact design to capture cell firing at high resolution.
  • The system allows simultaneous measuring and recording of dense cell activity data, supporting drug discovery, neuronal and cardiac disease research, and serving as an alternative to animal testing.
  • Offering the system on a trial basis aims to verify efficacy, promote technical development, accelerate market surveys based on user feedback, and advance commercialization using this MEA innovation.
Insights by Ground AI
Does this summary seem wrong?

58 Articles

All
Left
8
Center
21
Right
5
Rutland HeraldRutland Herald
+56 Reposted by 56 other sources
Center

Sony, SCREEN, and VitroVo to Start Trial Offer of MEA System Capable of Simultaneous Measuring and Recording Data from Approximately 237,000 Electrodes

Contributing to high-definition visualization of cellular activity and supporting research into neuronal and cardiac diseases and drug discovery

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 62% of the sources are Center
62% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States on Tuesday, June 3, 2025.
Sources are mostly out of (0)

Similar News Topics